InvestorsHub Logo
Followers 137
Posts 22806
Boards Moderated 0
Alias Born 04/08/2004

Re: bennyboy1 post# 180873

Friday, 02/08/2019 11:16:02 AM

Friday, February 08, 2019 11:16:02 AM

Post# of 457491
Benny,

YES

At present, there are no FDA-approved drugs for relieving Rett syndrome's core symptoms.


https://www.rettsyndrome.org/document.doc?id=156

http://www.anavex.com/wp-content/uploads/Rett_and_infantile_spasms_AV2-73_presentation.pdf

OFF LABEL PRESCRIPTION
https://en.wikipedia.org/wiki/Off-label_use

Preclinical data also validates ANAVEX®2-73 as a prospective platform drug for other neurodegenerative diseases beyond Alzheimer’s disease, Parkinson’s disease or Rett syndrome, more specifically, epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis and, more recently, tuberous sclerosis complex (TSC).[color=red][/color] ANAVEX®2-73 demonstrated significant improvements in all of these indications in the respective preclinical animal models.



REPLY TO:

Do you believe in ANAVEX today more than ever and what do you think our chances of early approval are?



Good luck and GOD bless,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News